Sunday, July 5, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, July 5 '26)

 


    Ann Intern Med


  1. Summary for Patients: Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone.
    Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-26-00217.
    PubMed        

  2. XIE Y, Choi T, Al-Aly Z
    Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.
    Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-26-00217.
    PubMed         Abstract available


    Antiviral Res

  3. YANG X, Wu L, Wan G, Chen R, et al
    The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata.
    Antiviral Res. 2026;252:106473.
    PubMed         Abstract available


    Arch Virol

  4. ALVES MCS, Falcao RM, de Jesus Palmeira OF, de Sa Leitao Paiva-Junior S, et al
    Genomic and epidemiological characterization of SARS-CoV-2 in Northeastern Brazil: a comprehensive analysis (2020-2024).
    Arch Virol. 2025;171:1.
    PubMed         Abstract available

  5. NEHUL S, Nagaraj SK, Narayan R, Singh A, et al
    A novel molecule inhibits SARS-CoV-2 RBD binding to the ACE2 receptor, blocks viral entry and exhibits antiviral activity in a murine model.
    Arch Virol. 2026;171:98.
    PubMed         Abstract available

  6. MOYUE X, Liang S, Ying X, Yang Y, et al
    Research progress of nucleocapsid protein of novel coronavirus: structure, function and targeted therapy.
    Arch Virol. 2026;171:120.
    PubMed         Abstract available

  7. CHEPURNOV A, Miroshnichenko S, Ivanov M, Solomatina M, et al
    Specific features of the infection caused by SARS-CoV-2 variants in Vero cell culture.
    Arch Virol. 2026;171:133.
    PubMed         Abstract available

  8. JONES LR, D'Andrea JS, Levite J, Brito M, et al
    Viral genotype and the pace of epidemic waves: an assessment from SARS-CoV 2 genomics and wastewater surveillance data.
    Arch Virol. 2026;171:163.
    PubMed         Abstract available


    BMC Pediatr

  9. ASAFO-AGYEI SB, Ameyaw E, Nguah SB, Paintsil V, et al
    Immunisation status and clinical outcomes in children admitted to a Paediatric emergency unit in Ghana: a prospective cohort study.
    BMC Pediatr. 2025;25:981.
    PubMed         Abstract available

  10. PU F, Hao YQ
    Impact of COVID-19 epidemic prevention and control measures on the incidence of asthma in children.
    BMC Pediatr. 2026;26:8.
    PubMed         Abstract available

  11. AVSAR H, Bulbul A, Bas EK, Uslu HS, et al
    Maternal-infant vitamin D coupling and neonatal hypocalcemia: a six-year cohort integrating preterm risk, onset timing, and pandemic effects.
    BMC Pediatr. 2026 Jan 27. doi: 10.1186/s12887-026-06532.
    PubMed        

  12. MOHAMMADI R, Barzegar H, Zamani Z, Gorji M, et al
    Hospitalization outcomes and laboratory correlations in pediatric MIS-C patients: a retrospective cross-sectional study in Tehran, Iran.
    BMC Pediatr. 2026;26:205.
    PubMed         Abstract available

  13. MIYAGI Y, Morimoto Y, Satake E, Iwashima S, et al
    Identification of key clinical features for pediatric respiratory syncytial virus infection using machine learning.
    BMC Pediatr. 2026;26:266.
    PubMed         Abstract available

  14. COBAN Y, Evren G, Yildizdas D, Zengin N, et al
    Burden, risk factors, and outcomes respiratory syncytial virus (RSV) infection in pediatric intensive care units in Turkiye (RSVP Study 2020-2024).
    BMC Pediatr. 2026 Mar 5. doi: 10.1186/s12887-026-06562.
    PubMed        

  15. AKALIN H, Kilic A, Ozcetin M, Yildiz I, et al
    The effect of Covid 19 pandemic on childhood obesity in Turkey.
    BMC Pediatr. 2026;26:310.
    PubMed         Abstract available

  16. SCHMIDT L, Feddern S, Kossow A, Niessen J, et al
    Severe acute COVID-19 and early long COVID signals in paediatric cohorts: an analysis of real-world data from two health departments, Germany.
    BMC Pediatr. 2026;26:280.
    PubMed         Abstract available

  17. HANSEN G, Holt T
    RSV bronchiolitis versus COVID-19: could pediatric intensive care units have done more during the pandemic?
    BMC Pediatr. 2026 Apr 11. doi: 10.1186/s12887-026-06850.
    PubMed        


    J Gen Virol

  18. KUOK DIT, Ma APY, Ching RHH, Ng KC, et al
    Assessment of influenza virus and coronavirus tropism, replication competence and disease severity in ex vivo and in vitro cultures of the human respiratory tract.
    J Gen Virol. 2026;107:002281.
    PubMed         Abstract available


    J Virol

  19. LI P, Zheng Y-M, Liu S-L
    Altered infectivity, cell-cell fusion, and immune evasion of SARS-CoV-2 BA.3.2 and LP.8.1 variants.
    J Virol. 2026 May 12:e0001626. doi: 10.1128/jvi.00016.
    PubMed         Abstract available

  20. MCCABE M, Groves HE, Getty E, Campbell E, et al
    Age-dependent expression and antiviral activity of interferon epsilon in respiratory epithelium.
    J Virol. 2026 May 12:e0057825. doi: 10.1128/jvi.00578.
    PubMed         Abstract available

  21. SIVARAJAN R, Kirchgatterer PC, Lawrenz J, Tanner-Matiz E, et al
    Tonic and early interferons defend against respiratory viruses in primary human lung organoid-derived air-liquid interface cultures.
    J Virol. 2026 May 20:e0210425. doi: 10.1128/jvi.02104.
    PubMed         Abstract available

  22. FAN L, Gao X, Feng W, Huang Q, et al
    SARS-CoV-2 ORF3a suppresses host antiviral interferon responses by promoting STUB1-mediated PTEN proteasomal degradation.
    J Virol. 2026 Jun 2:e0018626. doi: 10.1128/jvi.00186.
    PubMed         Abstract available

  23. SUSMA B, Spronken M, van Nieuwkoop S, Kalverda B, et al
    Increased or decreased numbers of CpG dinucleotide motifs in the genome of influenza A virus do not affect in vitro virus phenotype.
    J Virol. 2026 Jun 22:e0004726. doi: 10.1128/jvi.00047.
    PubMed         Abstract available

  24. ZHANG Q, Zhang Y, Sun H, Li H, et al
    Single-cell and spatial transcriptomic profiling reveals distinct immune landscapes in murine lungs infected with H1N1 versus H5N1 influenza viruses.
    J Virol. 2026 Jun 29:e0074626. doi: 10.1128/jvi.00746.
    PubMed         Abstract available

  25. KATO K, Okamura K, Nakamura Y, Iwata M, et al
    Influenza A virus infection induces initial proliferation of commensal Streptococcus pneumoniae in the larynx leading to dissemination into the lower respiratory tract.
    J Virol. 2026 Jun 29:e0055526. doi: 10.1128/jvi.00555.
    PubMed         Abstract available


    Pediatrics

  26. GERHART J, Leister-Tebbe H, Chan PLS, McComsey GA, et al
    Nirmatrelvir/Ritonavir for the Treatment of COVID-19 in Children Aged 6 Years and Older.
    Pediatrics. 2026 Jun 25:e2025073999. doi: 10.1542/peds.2025-073999.
    PubMed         Abstract available

  27. ZMUDA E, Hannon TS, Valentic J
    The Role of the Pediatrician to Promote Effective Approaches for Child and Adolescent Nutrition in Schools: Policy Statement.
    Pediatrics. 2026 Jun 15:e2026077404. doi: 10.1542/peds.2026-077404.
    PubMed         Abstract available

  28. MEHROTRA-VARMA S, Nguyen HQ, Henry S, Collins J, et al
    Long-Term Outcomes of Multisystem Inflammatory Syndrome in Children up to 4.5 Years After COVID-19.
    Pediatrics. 2026;158:e2025075578.
    PubMed         Abstract available


    PLoS One

  29. HUANG L, Wang TM, Sugimoto JD, Heberer KR, et al
    Association of SARS-CoV-2 infection with incident diabetes among U.S. Veterans in a prospective longitudinal cohort.
    PLoS One. 2026;21:e0351992.
    PubMed         Abstract available

  30. ALLARDET-SERVENT J, Hezard N, Pissier C, Bardin N, et al
    Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: A prospective cohort study.
    PLoS One. 2026;21:e0337792.
    PubMed         Abstract available

  31. NAZIR A, Shorfuzzaman M, Lotfi ML, Kamalov F, et al
    Forecasting COVID-19 new cases using NBEATS deep learning and mobility data.
    PLoS One. 2026;21:e0350264.
    PubMed         Abstract available

  32. WERTZ E, Babinska M, Batorski D, Louison-Lavoy D, et al
    Ad-based social media interventions increase belief accuracy and generate pro-social opinions among non-news readers.
    PLoS One. 2026;21:e0352588.
    PubMed         Abstract available

  33. HERNANDEZ-ORTIZ BA, Dos Santos TA, Appolinario CM, Arcila-Cardona AM, et al
    Spatial association of seabirds and aquatic birds with highly pathogenic avian influenza (H5N1) outbreaks in Brazil: A nationwide ecological and statistical modelling approach.
    PLoS One. 2026;21:e0350505.
    PubMed         Abstract available

  34. KEARNEY GD, Obi ON, Maddipati V, Levitin G, et al
    Social vulnerability and spatial patterns of COVID-19 mortality: Global implications for respiratory health equity.
    PLoS One. 2026;21:e0352270.
    PubMed         Abstract available

  35. KATUSIIME L, Agbola FW
    Determinants of mobile money loan disbursements: Evidence from Uganda's post pandemic digital credit boom.
    PLoS One. 2026;21:e0338535.
    PubMed         Abstract available

  36. KIERNAN EA, Guzman JD
    Paying in public: Peer effects, impression management, and willingness to pay on digital payment platforms.
    PLoS One. 2026;21:e0340550.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  37. CAO J, Liu S, Su C, Wang L, et al
    Genomic and structural evidence of SARS-CoV-2 and MERS-CoV in migratory birds.
    Proc Natl Acad Sci U S A. 2026;123:e2400023123.
    PubMed         Abstract available

  38. METZGER SM, Jones TC, Meier JIJ, Richter A, et al
    Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30.
    Proc Natl Acad Sci U S A. 2026;123:e2601806123.
    PubMed         Abstract available

  39. TYLLIS TS, Norton TS, Abbott C, McPeake DJ, et al
    B cell-intrinsic CXCR3 drives efficient generation of ectopic pulmonary germinal center responses to influenza A virus infection.
    Proc Natl Acad Sci U S A. 2026;123:e2535787123.
    PubMed         Abstract available

  40. SOEWONGSONO AC, Thompson A, Landis MJ
    Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.
    Proc Natl Acad Sci U S A. 2026;123:e2535042123.
    PubMed         Abstract available


    Vaccine

  41. YADEGARYNIA D, Keyvanfar A, Keyvani H, Tehrani S, et al
    Corrigendum to "Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial" [Vaccine 42(9) (2024) 2254-2259].
    Vaccine. 2026;88:128881.
    PubMed        

  42. BARBAROUX A, Serati I, Milhabet I
    Effectiveness and acceptability of an opt-out nudge to promote influenza vaccination among medical residents: A randomized controlled trial.
    Vaccine. 2026;89:128894.
    PubMed         Abstract available

  43. MORRIS SE, O'Halloran A, Sundaresan D, Olson SM, et al
    Public health benefits of maternal influenza vaccination among pregnant women and infants <6 months in the United States, 2011-2020.
    Vaccine. 2026;89:128895.
    PubMed         Abstract available

  44. HALWE NJ, Krammer F
    Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.
    Vaccine. 2026;89:128877.
    PubMed         Abstract available

No comments:

Post a Comment

My New Space

Most Popular Posts